These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epilepsy-associated bone mineral density loss should be prevented. Trevathan E Neurology; 2008 Jan; 70(3):166-7. PubMed ID: 18195262 [No Abstract] [Full Text] [Related]
4. Metabolic bone disease in gastrointestinal illness. Williams SE; Seidner DL Gastroenterol Clin North Am; 2007 Mar; 36(1):161-90, viii. PubMed ID: 17472881 [TBL] [Abstract][Full Text] [Related]
5. Metabolic bone disease associated with total parenteral nutrition. Buchman AL; Moukarzel A Clin Nutr; 2000 Aug; 19(4):217-31. PubMed ID: 10952792 [No Abstract] [Full Text] [Related]
6. [Demineralising osteopathies: new aspects of diagnostic imaging]. Kainberger F; Vasilevska V; Köller M; Lernbass-Wutzl I; Krestan C; Grampp S Wien Klin Wochenschr; 2003; 115 Suppl 2():79-86. PubMed ID: 15518152 [TBL] [Abstract][Full Text] [Related]
8. Bone disease in the inflammatory bowel disease population. Smith J; Lidofsky S Med Health R I; 2009 Apr; 92(4):125-7. PubMed ID: 19452755 [No Abstract] [Full Text] [Related]
9. [Evaluation of bone mass density after extensive resections within the alimentary tract]. Lampe P; Górka Z; Lesiecka M; Kurczabińska D Wiad Lek; 1997; 50(10-12):281-6. PubMed ID: 9557113 [TBL] [Abstract][Full Text] [Related]
10. NOF Task Force on bone mass measurement. Parfitt AM J Bone Miner Res; 1990 May; 5(5):533. PubMed ID: 2368633 [No Abstract] [Full Text] [Related]
11. [Bone changes in ulcerative colitis]. Huorka M; Payer J; Duris I; Killinger Z; Kratochvíl'ová H; Ondrejka P Vnitr Lek; 1997 Apr; 43(4):214-6. PubMed ID: 9601838 [TBL] [Abstract][Full Text] [Related]
12. [Possibilities of the laboratory diagnostic of metabolic skeletal changes]. Kolombo I; Hanus T; Kolombová J Cas Lek Cesk; 2005; 144(3):162-7. PubMed ID: 15887398 [TBL] [Abstract][Full Text] [Related]
13. [Indicators of bone mineral density in persons who had participated in cleaning-up operations after the Chernobyl AES accident]. Kharchenko VP; Rozhkova NI; Zubovskiĭ GA; Sergeev IE; Smirnov IuN; Rozhinskaia LIa; Rassokhin BM; Purtova GS Vestn Rentgenol Radiol; 1994; (2):38-40. PubMed ID: 7975171 [No Abstract] [Full Text] [Related]
14. Metabolic bone disease: a review and update. Mankin HJ; Mankin CJ Instr Course Lect; 2008; 57():575-93. PubMed ID: 18399611 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of physical development as a screening test for identification of children with prenosological bone mineralization disorder]. Kuchma VR; Cheprasov VV Gig Sanit; 2004; (4):39-42. PubMed ID: 15318612 [TBL] [Abstract][Full Text] [Related]
16. [Clinical application of bone densitometry]. García-Talavera JR An Med Interna; 1991 Dec; 8 Suppl 3():15-27. PubMed ID: 1793788 [No Abstract] [Full Text] [Related]
17. Measurements of bone mineral density. Mineral density in metabolic bone disease. Fischer M; Raue F Q J Nucl Med; 1999 Sep; 43(3):233-40. PubMed ID: 10568139 [TBL] [Abstract][Full Text] [Related]
18. [Value of bone densitometry in the determination of vertebral mineral density in participants of the clean-up after Chernobyl accident]. Kharchenko VP; Rassokhin BM; Zubovskiĭ GA Med Tr Prom Ekol; 2001; (2):29-32. PubMed ID: 11270148 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of noninvasive assessment methods of bone mineral content]. Kruse HP; Ringe JD Z Rheumatol; 1989; 48 Suppl 1():32-6. PubMed ID: 2686275 [No Abstract] [Full Text] [Related]